Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2/3 1

Status

Completed 5Not yet recruiting 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Venous Thromboembolism 1Pulmonary Embolism 1Peripheral Nervous System Diseases 1Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Specimen Handling 76Cisplatin 64Drug Therapy 63Carboplatin 63Bevacizumab 63Magnetic Resonance Spectroscopy 59Radiotherapy 57Gemcitabine 54Cyclophosphamide 54pembrolizumab 52Oxaliplatin 49Capecitabine 49toripalimab 44Paclitaxel 40tislelizumab 39Standard of Care 39fludarabine 36Injections 34Fluorouracil 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 28Nivolumab 28Surgical Procedures, Operative 27Irinotecan 27Docetaxel 27Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Rosuvastatin Calcium × 1 year × Clear all
NCT07303816 2026-06-01

STAT-CAT

Brigham and Women's Hospital

Phase 4 Not yet recruiting
4,000 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting
400 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡